BlackRock »

Corcept Therapeutics Incorporated shares owned by BlackRock

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $790M 16M 50.39
2024-09-30 $743M 16M 46.28

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jacobs Levy Equity Management
FMR
Morgan Stanley
First Trust Advisors
Charles Schwab Investment Management
Northern Trust

View all funds holding Corcept Therapeutics Incorporated